Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studies.
Faught E, Besson H, D'Souza W, Klein P, Reuber M, Rosenow F, Salas-Puig J, Insuga VS, Steinhoff BJ, Strzelczyk A, Szaflarski JP, Bourikas D, Daniels T, Floricel F, Friesen D, Laloyaux C, Villanueva V. Faught E, et al. Among authors: salas puig j. Epilepsy Behav. 2024 Sep;158:109922. doi: 10.1016/j.yebeh.2024.109922. Epub 2024 Jul 5. Epilepsy Behav. 2024. PMID: 38970892 Free article.
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis.
Szaflarski JP, Besson H, D'Souza W, Faught E, Klein P, Reuber M, Rosenow F, Salas-Puig J, Soto Insuga V, Steinhoff BJ, Strzelczyk A, Bourikas D, Daniels T, Floricel F, Friesen D, Laloyaux C, Villanueva V. Szaflarski JP, et al. Among authors: salas puig j. J Neurol. 2024 Jun;271(6):3169-3185. doi: 10.1007/s00415-024-12253-z. Epub 2024 Mar 4. J Neurol. 2024. PMID: 38436680 Free PMC article.
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
Villanueva V, Laloyaux C, D'Souza W, Faught E, Klein P, Reuber M, Rosenow F, Salas-Puig J, Insuga VS, Strzelczyk A, Szaflarski JP, Chinn C, Daniels T, Floricel F, Friesen D, Sendersky V, Besson H, Steinhoff BJ. Villanueva V, et al. Among authors: salas puig j. CNS Drugs. 2023 Sep;37(9):819-835. doi: 10.1007/s40263-023-01033-4. Epub 2023 Sep 9. CNS Drugs. 2023. PMID: 37684497 Free PMC article. Review.
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability.
Abraira L, Salas-Puig J, Quintana M, Seijo-Raposo IM, Santamarina E, Fonseca E, Toledo M. Abraira L, et al. Among authors: salas puig j. Epilepsy Behav Rep. 2021 Nov 14;16:100504. doi: 10.1016/j.ebr.2021.100504. eCollection 2021. Epilepsy Behav Rep. 2021. PMID: 34901817 Free PMC article.
Initiating antiepilepsy treatment: An update of expert consensus in Spain.
Villanueva V, Sánchez-Álvarez JC, Carreño M, Salas-Puig J, Caballero-Martínez F, Gil-Nagel A. Villanueva V, et al. Among authors: salas puig j. Epilepsy Behav. 2021 Jan;114(Pt A):107540. doi: 10.1016/j.yebeh.2020.107540. Epub 2020 Nov 24. Epilepsy Behav. 2021. PMID: 33243687
Tumor-associated status epilepticus: A prospective cohort in a tertiary hospital.
Vilaseca-Jolonch A, Abraira L, Quintana M, Sueiras M, Thonon V, Toledo M, Salas-Puig J, Fonseca E, Cordero E, Martínez-Ricarte F, Santamarina E. Vilaseca-Jolonch A, et al. Among authors: salas puig j. Epilepsy Behav. 2020 Oct;111:107291. doi: 10.1016/j.yebeh.2020.107291. Epub 2020 Jul 20. Epilepsy Behav. 2020. PMID: 32702656
139 results